Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP353 in Chronic Low Back Pain
NCT04238676Phase 2Completed
- Sponsor
- Persica Pharmaceuticals
- Start
- Jan 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of PP353 in chronic low back pain (CLBP), sponsored by Persica Pharmaceuticals. Started Jan 2020; status: completed.
02
Drugs
PP353
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04238676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238676.